Clinical Trials Directory

Trials / Completed

CompletedNCT00698152

A Clinical Investigation of ArComXL® Polyethylene in Total Hip Replacement

A Prospective, Non-controlled, Clinical Investigation of ArComXL® Polyethylene in Total Hip Replacement

Status
Completed
Phase
Study type
Observational
Enrollment
149 (actual)
Sponsor
Zimmer Biomet · Industry
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The purpose of this data collection is to determine long term survival rate of ArComXL® highly cross-linked polyethylene

Detailed description

Approximately 500 patients (cases) will be enrolled in this data collection effort and 10-year follow-up will be attempted. Follow-up will be obtained by sending a questionnaire directly to the patients by mail. The follow-up will be annually and only survivorship data will be collected. This data collection project was developed in order to determine the actual long-term (10-year) survival rate of Biomet's ArCom XL highly cross-linked polyethylene. Data will be collated for uncemented cases only. This will eliminate the possibility of cement or cement debris being a confounding variable. The data gathered will be collated and used to provide feedback to designing engineers, support marketing efforts, and answer potential questions from reimbursement agencies.

Conditions

Timeline

Start date
2006-01-23
Primary completion
2016-01-15
Completion
2016-01-15
First posted
2008-06-17
Last updated
2020-03-30

Locations

5 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00698152. Inclusion in this directory is not an endorsement.